/SYNSAM.ST
SYNSAM.ST Stock - Synsam AB (publ)
Healthcare|Medical - Instruments & SuppliesSTO
$66.50+0.00%
+$0.00 (+0.00%) • Dec 23
76
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.87
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $73.15
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SYNSAM.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$65.83 – $67.17
TARGET (TP)$76.47
STOP LOSS$61.18
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.51
52W High$67.00
52W Low$40.15
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $6.43B | $5.91B | $5.35B | $4.73B | $3.86B |
| Gross Profit | $4.84B | $4.46B | $4.07B | $3.64B | $2.91B |
| Gross Margin | 75.3% | 75.5% | 76.1% | 77.0% | 75.3% |
| Operating Income | $819.00M | $696.00M | $552.00M | $633.00M | $370.00M |
| Net Income | $366.00M | $311.00M | $328.00M | $51.00M | $-195,200,000 |
| Net Margin | 5.7% | 5.3% | 6.1% | 1.1% | -5.1% |
| EPS | $2.48 | $2.09 | $2.19 | $0.34 | $-1.30 |
Company Overview
Synsam AB (publ), through its subsidiaries, operates as an optical retailer in the Nordic Region. The company offers glasses, sunglasses, sports glasses, and contact lenses, as well as glasses and contact lens subscriptions, and eye examination services under the Synsam Lifestyle brand. It sells its products through directly owned and franchised stores, as well as through ecommerce in Sweden, Denmark, Norway, Iceland, and the Faroe Islands, and Finland. As of December 31, 2021, Synsam AB (publ) had 500 stores. Synsam AB (publ) was founded in 1968 and is headquartered in Stockholm, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
SYNSAM.STBeat Rate
31%
Last 16 quarters
Avg Surprise
-11.8%
EPS vs Estimate
Beats / Misses
5/10
1 met exactly
Latest EPS
$0.91
Q4 2025
EPS Surprise History
Q1 24
-4.7%
$0.41vs$0.43
Q2 24
-20.8%
$0.38vs$0.48
Q3 24
+23.9%
$1.14vs$0.92
Q4 24
-42.1%
$0.44vs$0.76
Q1 25
-22.7%
$0.51vs$0.66
Q2 25
0.0%
$0.60vs$0.60
Q3 25
-17.8%
$0.79vs$0.96
Q4 25
+14.2%
$0.91vs$0.80
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 14, 2026 | — | — | — | — |
Q1 2026 | Feb 20, 2026 | — | — | — | — |
Q4 2025 | Nov 18, 2025 | $0.80 | $0.91 | +14.2% | ✓ BEAT |
Q3 2025 | Aug 22, 2025 | $0.96 | $0.79 | -17.8% | ✗ MISS |
Q2 2025 | May 16, 2025 | $0.60 | $0.60 | 0.0% | = MET |
Q1 2025 | Feb 21, 2025 | $0.66 | $0.51 | -22.7% | ✗ MISS |
Q4 2024 | Nov 19, 2024 | $0.76 | $0.44 | -42.1% | ✗ MISS |
Q3 2024 | Aug 23, 2024 | $0.92 | $1.14 | +23.9% | ✓ BEAT |
Q2 2024 | May 17, 2024 | $0.48 | $0.38 | -20.8% | ✗ MISS |
Q1 2024 | Feb 21, 2024 | $0.43 | $0.41 | -4.7% | ✗ MISS |
Q4 2023 | Nov 17, 2023 | $0.78 | $0.61 | -21.8% | ✗ MISS |
Q3 2023 | Aug 22, 2023 | $0.83 | $0.94 | +13.3% | ✓ BEAT |
Q2 2023 | May 16, 2023 | $0.38 | $0.13 | -65.8% | ✗ MISS |
Q1 2023 | Feb 22, 2023 | $0.33 | $0.34 | +3.0% | ✓ BEAT |
Q4 2022 | Nov 16, 2022 | $0.78 | $0.53 | -32.1% | ✗ MISS |
Q3 2022 | Aug 24, 2022 | $1.00 | $0.65 | -35.0% | ✗ MISS |
Q2 2022 | May 11, 2022 | $0.53 | $0.66 | +24.5% | ✓ BEAT |
Q1 2022 | Feb 23, 2022 | $0.40 | $0.38 | -5.0% | ✗ MISS |
Q4 2021 | Nov 30, 2021 | — | $0.09 | — | — |
Q3 2021 | Sep 30, 2021 | — | $0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about SYNSAM.ST
What is SYNSAM.ST's current stock price?
Synsam AB (publ) (SYNSAM.ST) is currently trading at $66.50 per share. The stock has moved +0.00% today.
What is the analyst price target for SYNSAM.ST?
No analyst price targets are currently available for this stock.
What sector is Synsam AB (publ) in?
Synsam AB (publ) operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the STO exchange.
What is SYNSAM.ST's market cap?
Synsam AB (publ) has a market capitalization of $9.58 billion, making it a mid-cap company.
Does SYNSAM.ST pay dividends?
No, Synsam AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAMBEA.ST
Ambea AB (publ)
$141.30
Mkt Cap: $11.9B
ARJO-B.ST
Arjo AB (publ)
$31.52
Mkt Cap: $8.6B
ATT.ST
Attendo AB (publ)
$81.90
Mkt Cap: $12.4B
BIOG-B.ST
BioGaia AB (publ)
$102.40
Mkt Cap: $10.1B
BONEX.ST
Bonesupport Holding AB (publ)
$181.30
Mkt Cap: $11.9B
CEVI.ST
CellaVision AB (publ)
$155.00
Mkt Cap: $3.7B
DOXA.ST
Doxa AB (publ)
$0.44
Mkt Cap: $0.6B
RAY-B.ST
RaySearch Laboratories AB (publ)
$224.50
Mkt Cap: $7.7B
SECARE.ST
Swedencare AB (publ)
$37.70
Mkt Cap: $6.0B
XVIVO.ST
Xvivo Perfusion AB (publ)
$183.90
Mkt Cap: $5.8B
Explore stocks similar to SYNSAM.ST for comparison